Fund profile
MMC Ventures
London, United Kingdom
Not leading
About
MMC Ventures is a London-based venture capital firm that has been supporting early-stage tech entrepreneurs for over 20 years. Focused on transformative technology, MMC specializes in sectors such as artificial intelligence (AI), data-driven health, fintech, and enterprise software. The firm has built a reputation for deep industry expertise, particularly in AI and data science, where it is one of Europe's most active investors. Notable investments include Synthesia, Signal AI, and Current Health, the latter of which was acquired by Best Buy. MMC’s investment strategy is research-led, with a dedicated team of specialists who help identify and develop cutting-edge technologies. They typically invest in Seed and Series A rounds, but a significant portion of their funds is reserved for follow-on rounds, ensuring long-term support for portfolio companies. MMC also places a strong emphasis on partnering closely with founders, providing more than just capital; they offer resources like MMC Connect, a platform that facilitates introductions, coaching, and talent acquisition. In recent years, MMC has expanded its portfolio across Europe, backing companies in markets from the UK to Eastern Europe. The firm is committed to building businesses with the potential to drive technological advancements and create a positive impact on society, as evidenced by its status as one of the first B Corporations in venture capital.
Details
Highlights
$421.9k
Historical average check
$26.8M
Historical max check
July 2024
Last investment date
221
Investments
Healthtech & Wellness
Social media
Software & Apps
Web 3.0
Fintech & Financial services
AI & Deep Tech
Pharma
Real Estate & Proptech
Security & Privacy
Biotech
Other
Showing 0 lists
Contacts
Lists that include this fund